Florian Grebien joins LBI-CR as team leader to develop his independent research programme in acute myeloid leukemia (AML) in January 2014.
He completed his postdoctoral research in the team of Giulio Superti-Furga at the Research Centre for Molecular Medicine and will continue his outstanding research to elucidate the mechanistic basis of leukemogenesis.His team will be using a multidisciplinary approach, deploying a number of modern techniques, including shRNA and drug screening, expression profiling and proteomics. Within the forthcoming years, Dr. Grebien will develop a strong independent research team with international visibility, benefitting from the full support of the LBI-CR and the stimulating research environment provided by the LBI-CR's partner institutions. With this appointment the LBI-CR creates an attractive opportunity for an outstanding Austrian young research talent with the support of the LBG .
Please see the career section for current recruitments of the Grebien team.
"We are very proud to have attracted Dr. Grebien to our institute, as one of the most prolific young Austrian scientists in cancer research. His research is highly complementary to the LBI-CR core expertise and constitutes a significant boost to our research programme", commented director Richard Moriggl the recent recruitment. The LBI-CR has now again five individual teams in cancer research.
Dr. Grebien obtained his PhD at the University of Vienna with Prof. Ernst Müllner and Prof. Hartmut Beug. He has an outstanding publication record and was the recipient of the Sanofi Aventis Prize in 2005 and the Research Prize of the Austrian Association of Molecular Life Sciences and Biotechnology in 2012.